Life expectancy and cardiovascular mortality in persons with schizophrenia

@article{Laursen2012LifeEA,
  title={Life expectancy and cardiovascular mortality in persons with schizophrenia},
  author={Thomas M Laursen and Trine Munk-Olsen and Mogens Vestergaard},
  journal={Current Opinion in Psychiatry},
  year={2012},
  volume={25},
  pages={83–88}
}
Purpose of review To assess the impact of cardiovascular disease on the excess mortality and shortened life expectancy in schizophrenic patients. Recent findings Patients with schizophrenia have two-fold to three-fold higher mortality rates compared with the general population, corresponding to a 10–25-year reduction in life expectancy. Although the mortality rate from suicide is high, natural causes of death account for a greater part of the reduction in life expectancy. The reviewed studies… Expand
Excess early mortality in schizophrenia.
TLDR
The most urgent research agenda concerns primary candidates for modifiable risk factors contributing to this excess mortality, i.e., side effects of treatment and lifestyle factors, as well as sufficient prevention and treatment of physical comorbidity. Expand
Risk factors for early circulatory mortality in patients with schizophrenia
TLDR
Conditional logistic regression revealed that the duration of antipsychotic treatment was significantly associated with a lower risk of early circulatory mortality, and leukocyte counts at index hospitalization were significantly related with a higher risk. Expand
Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries
TLDR
Overall life expectancy was much lower among persons with bipolar disorder or schizophrenia, with life expectancy being from 11 to 20 years shorter than in the Nordic countries with well-developed welfare systems. Expand
Higher mortality and years of potential life lost of suicide in patients with schizophrenia
TLDR
Suicide had the most significantly greater risk of mortality among patients with schizophrenia as compared with the general population and the years of potential life lost (YPLL) associated with various causes of death was significantly higher. Expand
Mortality in schizophrenia: clinical and serological predictors.
TLDR
Because cigarette smoking confers an almost 5-fold risk of mortality, smoking cessation is an urgent priority and having an elevated level of antibodies to Epstein-Barr virus and to Herpes Simplex virus type 1 are also significant predictors of death from natural causes. Expand
Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors
TLDR
Given the extraordinary high risk of death due to smoking in schizophrenia, smoking cessation remains an urgent priority. Expand
Increased long-term mortality after myocardial infarction in patients with schizophrenia
TLDR
Patients with schizophrenia have not experienced a decline in mortality rate following myocardial infarction compared to the general population in long-term follow-up, and this finding highlights the need for research in MI follow- up care for patients with schizophrenia. Expand
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study.
TLDR
Schizophrenia patients had markedly premature mortality, and the leading causes were ischemic heart disease and cancer, which appeared to be underdiagnosed. Expand
Cardiovascular disease in patients with schizophrenia
TLDR
Coordinated care between tertiary providers, general practitioners and primary health care professionals should monitor the physical health of people with psychosis or schizophrenia at least annually and treatment should be offered accordingly. Expand
Accidental deaths among persons with schizophrenia: A nationwide population-based cohort study
TLDR
Schizophrenia is a strong independent risk factor for accidental deaths and substance abuse seems to constitute a substantial part of the association. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
Schizophrenia and increased risks of cardiovascular disease.
TLDR
The chief cause of excess premature mortality among patients with schizophrenia is CHD, caused mainly by their adverse risk factor profile, which is cigarette smoking, obesity leading to dyslipidemia, insulin resistance and diabetes, and hypertension. Expand
Life expectancy among persons with schizophrenia or bipolar affective disorder
TLDR
Life-expectancy was much shorter in persons with schizophrenia or bipolar disorder, and excess mortality from physical diseases and medical conditions exerts a far greater influence on the curtailed life-ex expectancy, when compared against the impact of death by external causes. Expand
Twenty-five year mortality of a community cohort with schizophrenia
TLDR
People with schizophrenia have a mortality risk that is two to three times that of the general population, and most of the extra deaths are from natural causes. Expand
Cardiovascular aspects of antipsychotics.
  • T. Raedler
  • Medicine
  • Current opinion in psychiatry
  • 2010
TLDR
More research is needed to better understand the relationship between schizophrenia, antipsychotic treatment and cardiovascular disease, and more effective treatment strategies need to be developed to reduce the burden of cardiovascular disease in schizophrenia. Expand
Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study
TLDR
Well designed, prospective mortality studies, with direct measurement of and adjustment for all known relevant risk factors for premature mortality, are needed to identify risk and protective medication and patient factors and to, ultimately, inform clinical practice. Expand
The Epidemiology of Excess Mortality in People with Mental Illness
TLDR
There is substantial excess mortality in people with mental illness for almost all psychiatric disorders and all main causes of death in developed countries, and whether it has changed over time is investigated. Expand
Heart disease treatment and mortality in schizophrenia and bipolar disorder - changes in the Danish population between 1994 and 2006.
TLDR
The higher mortality (with increasing trends) from heart disease in persons with schizophrenia compared to the rest of the cohort members can be explained partly by low rates of invasive cardiac procedures, but other reasons, such as antipsychotic-induced weight gain, primary prevention, and difficulty following smoking cessation advice could also be part of the explanation. Expand
Mortality in schizophrenia: a measurable clinical endpoint
TLDR
Data suggest that the mortality gap with the general population increased from the 1970s but may have peaked in the mid-1990s and the main causes of mortality are suicide, cancer and cardiovascular disease, with evidence that cancer mortality rates are similar to cardiovascular mortality rates. Expand
Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.
TLDR
The risk of CVD mortality in schizophrenia does not differ between clozapine and risperidone in adults despite known differences in risk profiles for weight gain and metabolic side effects, however, one cannot rule out an increased risk ofCVD mortality among those starting treatment at ages 55 years or older. Expand
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
TLDR
Overall and cause-specific standardized mortality ratios (SMR) in suicide were especially high in young patients in the first year after the first diagnosis of schizophrenia, and increased in both natural and unnatural causes of death. Expand
...
1
2
3
4
...